Go Pro

Haleon (HLN) Stock Forecast & Price Target

Haleon logo
$9.87 0.00 (0.00%)
Closing price 08/20/2026 03:58 PM Eastern
Extended Trading
$9.90 +0.03 (+0.30%)
As of 07:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Haleon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
4
Buy
5

Based on 11 Wall Street analysts who have issued ratings for Haleon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 2 have given a sell rating, 4 have given a hold rating, 3 have given a buy rating, and 2 have given a strong buy rating for HLN.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for HLN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Haleon and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLN Analyst Ratings Over Time

TypeCurrent Forecast
8/21/25 to 8/21/26
1 Month Ago
7/22/25 to 7/22/26
3 Months Ago
5/23/25 to 5/23/26
1 Year Ago
8/21/24 to 8/21/25
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
Hold
4 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/A$13.40$12.33
Forecasted UpsideN/AN/A44.02% Upside25.57% Upside
Consensus RatingHoldModerate BuyModerate BuyModerate Buy

HLN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HLN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Haleon Stock vs. The Competition

TypeHaleonConsumer Staples CompaniesBroader Market
Consensus Rating Score
2.45
2.23
2.53
Consensus RatingHoldHoldModerate Buy
Predicted UpsideN/A139.01% Upside13.00% Upside
News Sentiment Rating
Neutral News

See Recent HLN News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/11/2026 Reiterated RatingSector Perform
8/6/2026
Morgan Stanley logo
Morgan Stanley
4 of 5 stars
 Reiterated RatingOverweight
7/21/2026
Zacks Research logo
Zacks Research
5 of 5 stars
 DowngradeHoldStrong Sell
6/30/2026 Reiterated RatingHold (C)
6/16/2026 DowngradeStrong-BuyHold
4/30/2026 Reiterated RatingSell
3/17/2026 UpgradeStrong-Buy
1/21/2026 UpgradeHoldStrong-Buy
1/20/2026 Reiterated RatingBuy
9/16/2025DowngradeOverweightEqual Weight
The end may be near for these iconic stocks (Ad)

Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel

Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
9/10/2025 UpgradeNeutralBuy
5/27/2025 UpgradeNeutralOutperform$13.40+20.07%
1/8/2025DowngradeOutperformMarket Perform
10/1/2024UpgradeStrong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:48 AM ET.


Should I Buy Haleon Stock? HLN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, August 18, 2026. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

Haleon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Haleon plc:

  • The current stock price is around $720, reflecting a strong market position and investor confidence in Haleon's growth potential.
  • Haleon plc has a consensus rating of "Moderate Buy," indicating positive sentiment among analysts and suggesting potential for price appreciation.
  • Institutional investors own 6.67% of Haleon plc's stock, which often signals confidence in the company's long-term prospects and stability.
  • The company has recently seen significant increases in stakes from major hedge funds, such as AQR Capital Management, which grew its stake by 22.5% in the first quarter, indicating strong institutional interest.
  • Haleon plc offers a diverse product portfolio, including over-the-counter medicines and health products, catering to a broad consumer base and enhancing revenue stability.

Haleon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Haleon plc for these reasons:

  • Despite recent growth, the overall market for consumer healthcare can be volatile, influenced by changing consumer preferences and economic conditions.
  • Haleon plc's stock may face pressure from competition in the healthcare sector, which could impact market share and profitability.
  • Recent increases in institutional holdings may lead to volatility if these investors decide to sell, potentially affecting stock price stability.
  • The company is still relatively new in the market, having been formed through a separation from a larger pharmaceutical group, which may pose risks associated with establishing its brand identity.
  • Market conditions and economic factors can affect consumer spending on healthcare products, which may impact Haleon's sales and growth trajectory.

HLN Forecast - Frequently Asked Questions

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last twelve months. There are currently 2 sell ratings, 4 hold ratings, 3 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares.

According to analysts, Haleon's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, Haleon's stock had 2 downgrades and 1 upgrade by analysts.

Haleon has been rated by research analysts at Morgan Stanley, Rothschild & Co Redburn, Royal Bank Of Canada, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Haleon more than other "consumer staples" companies. The consensus rating score for Haleon is 2.45 while the average consensus rating score for "consumer staples" companies is 2.22. Learn more on how HLN compares to other companies.


This page (NYSE:HLN) was last updated on 8/21/2026 by MarketBeat.com Staff.
From Our Partners